Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0293 USD | 0.00% | -7.28% | -95.82% |
May. 30 | First Motion for Exclusivity Period Extension Filed by DMK Pharmaceuticals Corporation | CI |
May. 08 | Motion for Asset Sale Approved for DMK Pharmaceuticals Corporation | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-95.82% | 296K | |
+47.37% | 779B | |
+40.67% | 631B | |
-6.83% | 354B | |
+20.14% | 333B | |
+8.43% | 301B | |
+16.83% | 249B | |
-1.31% | 216B | |
+10.69% | 214B | |
+4.31% | 163B |
- Stock Market
- Equities
- DMKPQ Stock
- News DMK Pharmaceuticals Corporation
- Transcript : Adamis Pharmaceuticals Corporation, Q1 2022 Earnings Call, May 16, 2022